Boyds, MD, United States of America

Sunmin Lee

USPTO Granted Patents = 3 


 

Average Co-Inventor Count = 5.7

ph-index = 1


Company Filing History:


Years Active: 2016-2020

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Inventor Sunmin Lee

Introduction

Sunmin Lee, an accomplished inventor based in Boyds, MD, has made significant strides in the field of pharmaceutical innovations. With a total of three patents to his name, Lee is dedicated to developing groundbreaking solutions for cancer treatment and prevention, indicating a strong commitment to advancing medical research.

Latest Patents

One of Sunmin Lee's latest patents focuses on nuclear receptor modulators and their application in the treatment and prevention of cancer. These compounds, which can act as antagonists to the androgen receptor, include a compound of Formula I, with specific structural components denoted as R and X, as described in the patent documentation. The patent also encompasses pharmaceutically acceptable salts, solvates, and stereoisomers of these compounds. The resulting pharmaceutical compositions not only claim methods of use but also target various forms of cancer, including prostate cancer and other nuclear receptor-mediated conditions.

Career Highlights

Sunmin Lee serves under the company "The United States of America as Represented by the Secretary of the Department of Health and Human Services." His role involves leveraging his expertise in pharmacology and innovative research to contribute to significant therapeutic advancements. His work reflects a deep understanding of molecular interactions and their implications for cancer treatment.

Collaborations

Throughout his career, Sunmin Lee has collaborated with esteemed colleagues, including Jane B Neckers and Yeong Sang Kim. These partnerships foster a collaborative environment that enhances innovation and accelerates the pace of research aimed at developing effective cancer treatments.

Conclusion

Sunmin Lee's innovative contributions to the field, particularly in the area of nuclear receptor modulators, demonstrate his dedication to combating cancer through scientific advancement. His ongoing research and collaboration with other professionals will undoubtedly continue to impact the medical community and improve patient outcomes in the realm of oncology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…